Article Details
Retrieved on: 2021-06-28 16:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A phase 3 clinical trial of AstraZeneca's extended-release diabetes drug Bydureon in adolescents has met its primary endpoint. The study tested a ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here